| 摘要 |
<p>PCT No. PCT/JP95/01127 Sec. 371 Date Nov. 5, 1997 Sec. 102(e) Date Nov. 5, 1997 PCT Filed Jun. 7, 1995 PCT Pub. No. WO96/40659 PCT Pub. Date Dec. 19, 1996Described herein are N-hydroxyurea compounds having the ability to inhibit the 5-lipoxygenase enzyme and having formula (I) and the pharmaceutically acceptable salts thereof. The variables are described herein. These compounds are useful in the treatment or alleviation of inflammatory diseases, allergy and cardiovascular diseases in mammals and as the active ingredient in pharmaceutical compositions for treating such conditions. <IMAGE> (I)</p> |
